Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Kidney Injury: later-stage trial registry

3 of 10 indexed Kidney Injury trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 3 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Kidney Injury: 10 US clinical trials tracked, 3 recruiting.

Kidney Injury is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 2 of these trials.

Enrollment posture brief

Registry condition kidney-injury

OPEN 3 | RECR 30% | LATE 3 | EARLY 1 | RANK #1724 | SPON 2

Nearest open-share peer: Adrenocortical Carcinoma (30% recruiting · 10 trials)

Acute Leukemia of Ambiguous 80%Achondroplasia40%Kidney Injury (this)30%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Kidney Injury

Kidney Injury lists 3 open slots (30% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Kidney Injury on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Kidney Injury is recruiting below its size-band peers.

    3 of 10 indexed trials (30%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Kidney Injury research.

    University of Colorado, Denver accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Kidney Injury enrolment sits around 144 participants.

    Median target enrolment is 144 among the 10 trials that report a genuine target (sentinel values excluded). 4 of those (40%) plan for fewer than 100 participants.

  4. Kidney Injury splits between interventional and observational designs.

    6 interventional and 4 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 31Phase 42

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1
Phase 4 2

Named interventions

Most-linked intervention names on Kidney Injury records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
2 trials
MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR) Device
1 trials
Thiamine Hydrochloride Drug
1 trials
Iohexol infusion Diagnostic test
1 trials
p-aminohippurate clearance study Diagnostic test
1 trials
Data Inclusion Other
1 trials
MB-102 Drug
1 trials
Plasmalyte 6ml/kg/hr group Drug
1 trials

US sites by state

Facility locations filed on Kidney Injury trials. A trial with sites in several states counts in each.

Illinois 3 trials
Ohio 2 trials
New York 2 trials
North Carolina 2 trials
Colorado 2 trials
California 2 trials
Washington 1 trials
Utah 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Kidney Injury page

10 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kidney Injury condition card totals 10 registered trials; most-linked intervention Placebo; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.